EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Changes in SSM Assessed via 100 Hz ‐ VCTE Are Associated With Acute HVPG ‐Response to i.v. Propranolol: A European Multicentre Study

Paul Thöne, Dario Saltini, Joana Calvão iD, Lorenz Balcar iD, Tomas Guasconi, Georg Semmler iD, Paula Höfinger iD, Barbara Datterl, Albert Friedrich Stättermayer, Michael Trauner, Thomas Reiberger iD, José Presa und 3 weitere

Liver International · 2026-08 · 46 (8)

DOI: 10.1111/liv.70778 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Liver International, online erschienen am 09.07.2026. Verfasst von Paul Thöne und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Propranolol, Hypertension, Portal, Adrenergic beta-Antagonists, Portal Pressure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The acute hepatic venous pressure gradient (HVPG)‐response to i.v. propranolol predicts outcomes in patients with advanced chronic liver disease (ACLD) and clinically significant portal hypertension (CSPH). While non‐invasive tests (NIT) to monitor non‐selective beta‐blocker (NSBB)‐induced HVPG changes are lacking, spleen stiffness measurement (SSM) has shown promising results as a surrogate for HVPG. This study aimed to assess the correlation between changes in SSM at 100 Hz and HVPG upon acute i.v. propranolol.

Methods

ACLD patients with CSPH undergoing paired HVPG and SSM‐100 Hz assessments pre‐ and post‐i.v. propranolol (0.15 mg/kg) at three expert centres between 2019 and 2024 were included. HVPG‐response was defined as a ≥ 10% decrease in HVPG.

Results

Ninety‐four patients (63.8% males, median age 57.5 [Q1–Q3: 50.0–65.0] years, BMI 26.6 [22.8–31.1] kg/m 2 ) were included. Most had alcohol‐related liver disease (ALD)/metabolic‐associated liver disease (59.6%) or metabolic‐associated steatotic liver disease (11.7%). The median HVPG decreased from 17 (Q1–Q3: 15–20) mmHg to 16 (Q1–Q3: 12–19) mmHg post‐NSBB ( p < 0.001), with 45.7% achieving an acute HVPG‐response. SSM decreased by −8.7 ([Q1–Q3: −19.2; −0.2] kPa, p < 0.001). HVPG‐responders had a significant SSM decrease (−12.4 [Q1–Q3: −26.3; −5.6] kPa, p < 0.001), while non‐responders showed no change. A moderate correlation between relative changes in SSM and HVPG was observed (Spearman's ρ: 0.387; p < 0.001). Relative change in SSM achieved an area under the receiver operating characteristic curve (AUROC) of 0.717 (95% CI: 0.614–0.820, p < 0.001) for diagnosing HVPG‐response.

Conclusion

SSM‐100 Hz dynamics are associated with HVPG changes upon i.v. propranolol administration. Although the discriminative ability of changes in SSM was insufficient for clinical use, they may serve as a surrogate of efficacy in clinical trials investigating medical therapies for portal hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropranololHypertension, PortalAdrenergic beta-AntagonistsPortal PressureSpleenElasticity Imaging TechniquesHumansFemaleMaleMiddle AgedAgedEurope

Stichwörter der Autor:innen

beta blockercirrhosishepatic venous pressure gradientportal hypertensionspleen stiffness

Substanzen

PropranololAdrenergic beta-Antagonists

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Vienna Hepatic Hemodynamic Lab, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Clinical Research Group MOTION, Medical University of Vienna, Vienna, Austria.
  • Severe Liver Diseases Unit (M.E.C.), Department of Medical Specialities, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, Modena, Italy.
  • Liver Unit-ULSTMAD, Hospital Center of Trás-os-Montes and Alto Douro, Vila Real, Portugal.
  • Pharmacy Department, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Joana Calvão, Lorenz Balcar, Georg Semmler, Paula Höfinger, Thomas Reiberger, Mattias Mandorfer, Mathias Jachs

Zitieren

APA

Thöne, P., Saltini, D., Calvão, J., Balcar, L., Guasconi, T., Semmler, G., Höfinger, P., Datterl, B., Stättermayer, A. F., Trauner, M., Reiberger, T., Presa, J., Schepis, F., Mandorfer, M., & Jachs, M. (2026). Changes in SSM Assessed via 100 Hz ‐ VCTE Are Associated With Acute HVPG ‐Response to i.v. Propranolol: A European Multicentre Study. Liver International, 46(8). https://doi.org/10.1111/liv.70778

Vancouver

Thöne P, Saltini D, Calvão J, Balcar L, Guasconi T, Semmler G, et al. Changes in SSM Assessed via 100 Hz ‐ VCTE Are Associated With Acute HVPG ‐Response to i.v. Propranolol: A European Multicentre Study. Liver International. 2026;46(8). doi:10.1111/liv.70778

BibTeX
@article{Thne2026,
  author = {Thöne, Paul and Saltini, Dario and Calvão, Joana and Balcar, Lorenz and Guasconi, Tomas and Semmler, Georg and Höfinger, Paula and Datterl, Barbara and Stättermayer, Albert Friedrich and Trauner, Michael and Reiberger, Thomas and Presa, José and Schepis, Filippo and Mandorfer, Mattias and Jachs, Mathias},
  title = {Changes in SSM Assessed via 100 Hz ‐ VCTE Are Associated With Acute HVPG ‐Response to i.v. Propranolol: A European Multicentre Study},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {8},
  doi = {10.1111/liv.70778}
}
Kostenlos starten →